Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
about
A new strategy to fight antimicrobial resistance: the revival of old antibioticsCommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicPrevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odysseyUse of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescentsManagement of community-associated methicillin-resistant Staphylococcus aureus infections in children.Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois.Staphylococcus aureus - antimicrobial resistance and the immunocompromised child.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerMolecular epidemiology and antimicrobial resistance of methicillin-resistant Staphylococcus aureus bloodstream isolates in Taiwan, 201070-year-old-man with left-sided facial swellingNational athletic trainers' association position statement: skin diseases.Use of ribotyping to retrospectively identify methicillin-resistant Staphylococcus aureus isolates from phase 3 clinical trials for tigecycline that are genotypically related to community-associated isolates.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theFusidic acid and clindamycin resistance in community-associated, methicillin-resistant Staphylococcus aureus infections in children of Central Greece.Methicillin-resistant Staphylococcus aureus, Hawaii, 2000-2002.Community-associated methicillin-resistant Staphylococcus aureus in pediatric patientsCommunity-associated meticillin-resistant Staphylococcus aureusCommunity-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention.Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Prevalence of inducible clindamycin resistance in staphylococcal isolates at a Korean tertiary care hospital.A sentinel fatal paediatric case of community-associated methicillin-resistant Staphylococcus aureus in CanadaSignificance of Negative Cultures in the Treatment of Acute Hematogenous Bone and Joint Infections in Children.Incidence of constitutive and inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci in a community and a tertiary care hospital.Blinded comparison of repetitive-sequence PCR and multilocus sequence typing for genotyping methicillin-resistant Staphylococcus aureus isolates from a children's hospital in St. Louis, Missouri.Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among a collegiate football team.Characterization of Staphylococcus aureus mutants expressing reduced susceptibility to common house-cleanersPotential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure.The prevalence of inducible and constitutive clindamycin resistance among the nasal isolates of staphylococci.What is community-associated methicillin-resistant Staphylococcus aureus?
P2860
Q21131083-F1B9F1E3-4900-4700-959E-BCDF00458266Q24614464-251B6DD2-90E1-434B-BCC8-EFD22EF84ED7Q24797274-6D40EC4C-A333-406E-8DD4-DB0C1AA07790Q28235095-A78D8C8D-FD7A-47A2-B725-5AC2BB2DACD9Q30832465-1078C332-0ED3-427E-8E64-487737D5CC06Q33264579-D0C6D343-A33A-4356-85B5-812A781C0281Q33483064-934F5324-7C77-4EC1-84F6-1CEF8529ED01Q33604961-75286D6E-B8C2-4B26-AF9F-3106A451F486Q33650105-DD18C8EF-74C3-4C69-A9E1-88F974DF074EQ33812571-3A38028F-BFC2-4CFC-B429-5DBAF195A164Q33820039-59856BC8-3F36-41A4-8504-5AEE1BA5B8EBQ33984713-9A9EF49D-D0D4-4316-8811-1A4F331F8E3CQ34123752-2C6611BC-89E3-41B4-9E0C-AC334BBFE709Q34212799-F4958743-6B7F-4EF7-B2C7-3DFAC7878D00Q34481932-A8433CFD-E923-44E6-84C7-BA55FB312BF8Q35873382-E140BCF9-E173-494D-A36D-9069D5513CDCQ36009370-B07C5D1B-7C1C-4E14-A532-194373DDEC9DQ36438720-61C7A0DA-D105-4E57-AA9F-235235F4EC1AQ36703883-FBF6E4AA-50AE-40A7-B140-E05C668E0478Q36718474-BA4F3CF4-7016-4BC2-AE63-67E17B2AB4A5Q37205609-4BFAF1CD-E26D-48E2-B9BC-3843317334B6Q37333745-B5408CC4-2E90-442C-9BAF-9B1116860644Q40261236-2BE5ED38-B938-40B9-840C-5BA614CF2391Q40938285-BF64DE39-52AB-4C7E-B482-2BEAF3508882Q41483601-7C36AE18-3978-4BC5-A9C9-7AC757F84603Q41817469-571D95FB-F7C2-4CD7-AA58-8CE832017034Q41823630-3736F6D6-9EC3-4734-9ED4-8E5754C359BBQ42845017-88875625-11F4-45BF-9143-6D798BCA64C7Q42968827-F9DABC56-4765-4998-BD8A-E919E5B6CF51Q46052140-9DEA431F-0C3D-4467-9E86-BE507EA85824
P2860
Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Clindamycin treatment of invas ...... hylococcus aureus in children.
@en
Clindamycin treatment of invas ...... hylococcus aureus in children.
@nl
type
label
Clindamycin treatment of invas ...... hylococcus aureus in children.
@en
Clindamycin treatment of invas ...... hylococcus aureus in children.
@nl
prefLabel
Clindamycin treatment of invas ...... hylococcus aureus in children.
@en
Clindamycin treatment of invas ...... hylococcus aureus in children.
@nl
P2093
P1476
Clindamycin treatment of invas ...... hylococcus aureus in children.
@en
P2093
Edward O Mason
Gerardo Martínez-Aguilar
Sheldon L Kaplan
Wendy A Hammerman
P304
P356
10.1097/00006454-200307000-00006
P577
2003-07-01T00:00:00Z